Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Charles River Labs and WuXi PharmaTech (药明康德)...
The proposed merger between Charles River Laboratories...
In an open letter to customers, which was obtained by...
This week's announcement that some of Charles River...
The proposed merger between Charles River Labs and WuXi...
In the aftermath of the breakup of the Charles River Labs...
China Kanghui Holdings reported increased Q2 results and...
QIAGEN expects its China revenues to double this year,...
WuXi PharmaTech will spend $100 million to build a new...
China’s 12th Five Year Plan (2011-2015) for...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
